Clifford S. Mintz, PhD is a seasoned bioscience professional with over 18 years of experience in drug discovery/development, biomanufacturing, commercialization and regulatory compliance. Dr Mintz is also a professional medical/healthcare writer and a regular contributor to life sciences business publications.
Dr. Mintz began his career as a tenure-track professor in the Department of Microbiology and Immunology at the University of Miami School of Medicine. After leaving academia in 1994, Dr. Mintz was a management consultant to a number of privately and publicly held biopharmaceutical companies. Dr Mintz is a co-founder of Prolong Pharmaceuticals, a protein-based drug delivery company and most recently Artemes Technologies, a medical technologies development firm.
At present, he is a science/business advisor to several start-up biotechnology companies and an Adjunct Professor at Georgetown University School of Medicine.
Cliff received a B.S. in microbiology/animal science from Cornell University, a Ph.D. in Bacteriology from the University of Wisconsin-Madison and performed his post-doctoral studies at Oregon Health Sciences University and the College of Physicians & Surgeons, Columbia University.
Last Editorial Review: March 3, 2015
Copyright © 2015 InPress Media Group. All rights reserved. Republication or redistribution of InPress Media Group content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group. InPress Media Group shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. ADC Review / Journal of Antibody-drug Conjugates is a registered trademarks and trademarks of InPress Media Group around the world.